Corticosteroid Tapering Guidelines

Evidence-Based Rationale

For corticosteroid courses lasting 3-10 days, tapering is not necessary, as stated by the National Asthma Education and Prevention Program guidelines, which indicate that no tapering is needed for short courses when patients are started on inhaled corticosteroids 1
The threshold for HPA axis suppression requiring tapering is typically doses equivalent to at least 20mg/day of prednisone for more than 3-4 weeks, according to the Annals of the Rheumatic Diseases 2

Tapering becomes necessary when glucocorticoids are used for more than 3-4 weeks, as prolonged use can cause HPA axis suppression necessitating gradual withdrawal to prevent adrenal insufficiency, as noted by the Annals of the Rheumatic Diseases 2
If the patient has been on chronic corticosteroids previously, they may have residual HPA axis suppression and could require stress-dose coverage or a taper even for a short course, as stated by the Annals of the Rheumatic Diseases 2

The British Society of Gastroenterology notes that patients receiving prolonged courses of corticosteroids should have tapering and be warned about steroid withdrawal syndrome, which includes symptoms such as weakness, nausea, and arthralgia, although a 7-day course does not constitute "prolonged" exposure 3
Patients with a history of prior chronic corticosteroid use within the past year may have residual HPA axis suppression and could require a taper or stress-dose coverage even for short courses 3

The British Society of Gastroenterology recommends monitoring for withdrawal symptoms, such as significant weakness, nausea, or joint pain, after stopping corticosteroids, although this is unlikely after a 7-day course at 10mg daily 3

The American Society of Hematology recommends against prolonged courses (>6 weeks) of prednisone and in favor of short courses (≤6 weeks) for newly diagnosed immune thrombocytopenia, recognizing that extended exposure increases harm without additional benefit 4
Guidelines for chronic conditions like autoimmune hepatitis, immune thrombocytopenia, and rheumatoid arthritis appropriately recommend tapering for courses exceeding 6 weeks, but these recommendations are inappropriately extrapolated to short courses 4, 5, 6, 7

Extended courses expose patients to additional days of corticosteroid side effects including hyperglycemia, hypertension, sleep disturbances, mood changes, and gastric irritation without clinical benefit 4

Patients with chronic inflammatory diseases (e.g., inflammatory bowel disease) that necessitate prolonged glucocorticoid therapy—typically 6–8 weeks—should undergo a tapering regimen to prevent adrenal insufficiency and withdrawal symptoms 8